BioSpace News Archive

Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that Aaron Schuchart will be joining the company as Chief Business Officer starting on May 6, 2020. In this role, Mr. Schuchart will coordinate with Lumos Pharma management and operational teams to identify and advance business development opportunities for the company as part of its strategy to expand its pipeli

Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A. focused on research and development of treatments for rare and ultra-rare disorders, today announced its support for Fabry Disease Awareness Month and highlighted the company’s continued commitment to patients, caregivers and families impacted by this debilitating rare disease

10x Genomics (Nasdaq: TXG) today announced it will report financial results for the first quarter 2020 after market close on Monday, May 11, 2020. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. Live audio of the webcast will be available on the “Investors” section of the company website at: www.10

CVS Health Corporation announced that, by order of its Board of Directors, its 2020 Annual Meeting of Stockholders will now be held solely by remote communication.

Incyte (Nasdaq:INCY) announces the appointment of Christine Lennon as the General Manager for Incyte Biosciences Canada, expanding the Company’s North American footprint. In her role, Christine will be responsible for the development of Incyte’s medical, regulatory and commercial strategy in Canada. “We are very pleased that Christine has joined Incyte as we expand our business in North America and establish a commercial

1,748 Community Oncology Clinics and/or Practices Have Closed, Been Acquired by Hospitals, Merged, or Reported Financial Struggles Since 2008 Significant Increase in Community Oncology Practice Mergers and/or Acquisitions with Other Non-Hospital Practices or Corporate Entities as Hospital Acquisitions Continue

Dr. Akrum “Aki” Alzubaidi, an Interventional Pulmonologist at National Jewish Health, and founder and co-CEO of Eon, will be joined by the Essential Patient Taskforce for a live webinar on April 29.

Arena Pharmaceuticals, Inc. announced that on April 15, 2020, the Compensation Committee of its Board of Directors granted inducement stock options to purchase an aggregate of 39,800 shares of its common stock to nine new employees and 1,320 inducement restricted stock units to one new employee.

Aesthetic Medical International Holdings Group Limited, a leading provider of aesthetic medical services in China, announces its financial results for the fourth quarter and fiscal year ended December 31, 2019.

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that its subsidiary, MediPharm Labs Australia Pty Ltd (“MediPharm Labs Australia”), has entered into an agreement to supply pharmaceutical-quality (GMP certified),